Navigation Links
Medbox, Inc. Announces Top-Tier Rating by Dun & Bradstreet Credibility Corporation
Date:5/9/2012

HOLLYWOOD, Calif., May 9, 2012 /PRNewswire/ -- Medbox, Inc. (Pinksheets: MDBX) (www.medboxinc.com) announced today that the company, through its wholly owned Subsidiary, Prescription Vending Machines, Inc., has upgraded its credit worthiness and corporate stability ratings to top tier status with Dun & Bradstreet Credibility Corp.  Dun & Bradstreet is a company that is steeped in tradition, woven into the fiber of corporate America in the credit reporting industry, dating back to 1837.

D&B's proprietary set of key ratings include the PAYDEX® Score, a predictive indicator for paying bills on time; the Financial Stress Score, an indicator of financial stress in the next 12 months; and the Credit Limit Recommendation, which provides guidelines for extending business credit and an overall D&B Rating which addresses the overall assessment of a business.

Medbox, Inc. (DUNS: 93-072-9434) ranked in the top two tiers in every one of the criteria listed above as well as in the 87th percentile in commercial credit score as compared to other businesses nationally.

"With the posting of our latest financials and the recent top-tier rating by D&B, we are setting the stage for what is proving to be our most successful year ever," stated Dr. Bruce Bedrick, CEO of Medbox, Inc.

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Tokyo and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, urgent care centers, clinics, hospitals, and medical groups worldwide.

Medbox, Inc. is a publicly traded company, and is listed on the OTC Board, ticker symbol MDBX.

For mo
'/>"/>

SOURCE Medbox, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Medbox, Inc. Announces New Board of Directors After Acquisition of Prescription Vending Machines, Inc.
2. Medbox, Inc. Announces Approval in Colorado House Bill (HB1043)
3. Medbox, Inc. Announces New Product Line for 2012
4. NIAID announces 25 new awards to develop radiation countermeasures
5. Aware Announces Q3 2008 Earnings Conference Call
6. Governor Doyle announces historic genomic research collaboration
7. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
8. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
9. Parkinsons Disease Foundation announces award of $150,000
10. Jefferson Department of Surgery announces new pancreas tumor registry
11. NAS announces initiative to connect entertainment industry with top experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 5, 2015 In Brazil , ... already using these solutions and 42 percent planning to invest ... approximately 25 percent of the companies will be investing in ... majority of companies in the region are currently opting for ... model will command significant attention in the coming years. This ...
(Date:3/4/2015)... 04, 2015 Research and Markets ... the "Global Biometrics Market Forecast and Opportunities, ... The market for biometric authentication systems is projected ... till 2020 The driving forces for ... needs, government projects and constant development in technology. ...
(Date:3/3/2015)... 3, 2015 Cryoport, Inc. (OTCBB: ... cryogenic logistics solutions for the life sciences ... cell lines, clinical research organizations, vaccine manufacturers, ... the expansion of its relationship with ... Hutch") Clinical Research Division with the inclusion ...
Breaking Biology News(10 mins):Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
... East Asia is where the wolf was tamed and became the ... But now researchers at the Royal Institute of Technology (KTH) in ... "For the first time in world history it is possible to ... in time, and how many wolves were tamed," says Peter Savolainen, ...
... and other aquatic fauna in recent centuries are not restricted ... that species in rivers and lakes worldwide also experienced sharp ... is frequently overlooked by natural resource managers, according to an ... , Authors Paul Humphries and Kirk Winemiller argue that as ...
... Three out of ten women who undergo polar body ... of polar body analysis (PBA) is described by researchers in ... edition of Deutsches rtzeblatt International , in which they ... Int 2009; 106(33): 533-8). Polar bodies are by-products of ...
Cached Biology News:Shifting baselines confound river restoration 2New developments in reproductive medicine 2
(Date:3/6/2015)... 2015 Global Specimen Solutions, Inc. ... on specimen management and informatics, announced today that ... Solutions, Inc. is excited to catapult our growing ... will further enhance our proprietary informatics tools and ... research. GSS has proved rapid market uptake of ...
(Date:3/6/2015)... March 6, 2015 BioSpecifics Technologies Corp. (NASDAQ: ... in class collagenase-based products marketed as XIAFLEX ® ... XIAPEX ®  in the EU, announced today that it ... at 8:30 a.m. ET on Friday, March 13, 2015 ... financial results and provide a corporate update. ...
(Date:3/6/2015)... 2015   Senomyx , Inc. (NASDAQ: ... technologies to discover, develop, and commercialize novel flavor ingredients ... John Poyhonen , the Company,s President and Chief ... President and Chief Financial Officer, will present an overview ... March 11, at 2:00 p.m. Eastern Time (11:00 a.m. ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Transparency Market Research ... and Other Crops - Global Industry Analysis, Size, Share, Growth, ... the global isoxaflutole market was valued at US$ 116.3 Mn ... by 2020, expanding at a CAGR of 5.1% from 2014 ... isoxaflutole stood at 2,569.5 kilo tons in 2013. , Isoxaflutole ...
Breaking Biology Technology:Global Specimen Solutions, Inc. Closes Series A Funding 2Global Specimen Solutions, Inc. Closes Series A Funding 3BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2014 Financial Results on Friday, March 13, 2015 2SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE THE 27TH ANNUAL ROTH CONFERENCE 2Isoxaflutole Market is Expected to Reach US$ 163.0 Mn by 2020 : Transparency Market Research 2Isoxaflutole Market is Expected to Reach US$ 163.0 Mn by 2020 : Transparency Market Research 3
... DCGN ) today announced its consolidated financial results ... conference call to discuss the,year,s results and operating highlights ... EDT/12 noon GMT (details below)., Net loss for ... to $85.5 million for the full year 2006. Basic ...
... JOSE, Calif., March 12 Oncolys BioPharma,Inc. (Tokyo, ... USA),announced today that they have entered into a ... throughout Asia, Tacere,s,RNA interference (RNAi)-based Hepatitis C virus ... agreement resulted from the,strategic alliance entered into by ...
... WILMINGTON, Del., March 12 AstraZeneca (NYSE:,AZN) announced ... two,pivotal Phase III studies for vandetanib, the company,s ... of,non-small cell lung cancer (NSCLC). The two studies ... cell lung Cancer) and ZEAL (ZACTIMA,Efficacy with Alimta ...
Cached Biology Technology:deCODE Genetics Announces Full-year 2007 Financial Results 2deCODE Genetics Announces Full-year 2007 Financial Results 3deCODE Genetics Announces Full-year 2007 Financial Results 4deCODE Genetics Announces Full-year 2007 Financial Results 5deCODE Genetics Announces Full-year 2007 Financial Results 6deCODE Genetics Announces Full-year 2007 Financial Results 7deCODE Genetics Announces Full-year 2007 Financial Results 8deCODE Genetics Announces Full-year 2007 Financial Results 9Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug 2Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug 3AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC) 2AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC) 3
... antibody raised against a partial recombinant MAK. ... ~ 457 a.a) partial recombinant protein with GST ... Accession: BC039825 ... OMIM: 154235, GeneID: ...
...
Mouse polyclonal antibody raised against a partial recombinant DDEF2. NCBI Entrez Gene ID = 8853...
Mouse monoclonal antibody raised against a full length recombinant SCGB3A2. NCBI Entrez Gene ID = SCGB3A2...
Biology Products: